Hope For Alzheimer's-Related Psychosis? Schizophrenia Drug Reduces Hallucinations & Delusions In Recent Trial

Schizophrenia Drug Shows Promise Against Hallucinations And Delusions In Alzheimer's Patients

Credit: AI

Text

Updated Nov 19, 2026 | 08:00 PM IST

SummaryBristol Myers Squibb's schizophrenia drug Cobenfy, made by combining xanomeline and trospium chloride, reportedly showed promising results in controlling psychosis symptoms in patients with Alzheimer's disease.

End of Article